Market intelligence - Page 2

Stay up to date with the latest Market intelligence updates from the global world pharmaceuticals industry

Diagnosis merger – examining the mega M&A trend 11 November, 2014 The pharmaceutical industry is witnessing a new wave of mergers...

Eastern promise - the Chinese pharmas’ market 11 November, 2014 With healthcare costs and expenditure rising in China, healthcare...

Space to grow – treating Type 2 diabetes 14 April, 2014 Type 2 diabetes is growing in prevalence worldwide, particularly in...

Better together 09 December, 2013 GlobalData reports on the latest developments and trends in a buoyant...

A good deal better: pharmaceutical mergers and acquisitions 11 October, 2013 The global pharmaceutical sector continues to witness significant mergers...

Positive reaction: public opinion of adjuvants 05 July, 2013 Since the emergence of vaccines, eliciting a strong immune response among...

Riding pharma’s R&D rollercoaster 27 March, 2013 Following a period of decline in delivery, and in anticipation of...

Shaping the future of clinical data management 06 March, 2013 Data is the bedrock of any clinical trial, so changes to the processes...

Coming together in hard times: biotech funding 22 February, 2013 The productivity of the biotech industry is still in question and...

Features By Category view all



Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.